SCHEMBL30633320

SCHEMBL30633320

CCN(C(=O)O)c1cc(-c2ccc3[nH]nc(N)c3c2)ccn1.Nc1n[nH]c2ccc(-c3ccnc(NC(=O)Nc4cccc(CO)c4)c3)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 13/20 0.46
▸ KIT P10721 10/20 0.46
▸ FLT3 P36888 7/20 0.46
▸ PDGFRA P16234 3/20 0.43
▸ JAK2 O60674 3/20 0.41
▸ F11 P03951 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ PLK4 O00444 5/20 0.39
▸ ROCK2 O75116 5/20 0.39
▸ LCK P06239 5/20 0.39
▸ CSF1R P07333 5/20 0.39
▸ FLT1 P17948 5/20 0.39
▸ FLT4 P35916 5/20 0.39
▸ DYRK1A Q13627 5/20 0.39
▸ MARK2 Q7KZI7 5/20 0.39
▸ AURKB Q96GD4 5/20 0.39
▸ AURKA O14965 4/20 0.39
▸ NTRK2 Q16620 4/20 0.39
▸ RPS6KB1 P23443 4/20 0.39
▸ MARK3 P27448 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30633303 0.91 JAK2 (0.48) KDRKITFLT3JAK2F11
SCHEMBL30633336 0.90 KDR (0.51) KDRKITFLT3PDGFRAJAK2
SCHEMBL30633299 0.89 KDR (0.51) KDRKITFLT3PDGFRAJAK2
SCHEMBL26686267 0.89 KDR (0.51) KDRKITFLT3PDGFRAJAK2
SCHEMBL30633386 0.89 JAK2 (0.41) KDRKITFLT3JAK2MAPK1
SCHEMBL30633326 0.88 DYRK1A (0.45) JAK2MAPK1DYRK1ACLK2
SCHEMBL30633306 0.86 CNR1 (0.51) KDRKITFLT3JAK2MAPK1
SCHEMBL30633377 0.84 JAK2 (0.51) KDRKITFLT3JAK2MAPK1
SCHEMBL30633315 0.84 JAK2 (0.46) KDRKITFLT3JAK2MAPK1
SCHEMBL30633368 0.80 JAK2 (0.38) KDRJAK2F11MAPK1PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback